Sanofi | SNY - Ebit




Sanofi reported EUR5.06B in EBIT for its fiscal quarter ending in September of 2024.

Ebit Change Date
AbbVie USD 5.33B 2.53B Dec/2024
Amgen USD 4.03B 11M Dec/2024
AstraZeneca USD 4.2B 119M Dec/2024
Bristol-Myers Squibb USD 4.21B 2.03B Dec/2024
Canopy Growth CAD -45943000 55.91M Sep/2024
Corcept Therapeutics USD 45.6M 10.01M Sep/2024
Drreddys Laboratories INR 16.8B 1.13B Sep/2024
Eli Lilly USD 5.63B 3.88B Dec/2024
Galapagos EUR -62721000 8.42M Dec/2024
Genmab DKK 2.16B 58M Dec/2024
GlaxoSmithKline GBP 1.43B 1.33B Dec/2024
Glaxosmithkline GBP 220M 2.95B Sep/2024
Indivior 9M 51M Sep/2024
J&J USD 5.35B 1.81B Dec/2024
Merck USD 5.22B 805M Dec/2024
Novartis USD 4.86B 286M Dec/2024
Novartis USD 3.65B 1.3B Sep/2024
Pacira USD 48.91M 9.2M Sep/2024
Perrigo USD 182.4M 212.3M Sep/2024
Pfizer USD 4.62B 2.42B Dec/2024
Prestige Brands USD 91.96M 7.62M Dec/2024
Roche Holding CHF 11.29B 2.68B Jun/2024
Sanofi EUR 2.08B 1.69B Dec/2024
Sanofi EUR 5.06B 2.03B Sep/2024
Supernus Pharmaceuticals USD 67.7M 41.4M Sep/2024
UCB EUR 334M 163M Jun/2024
Zoetis USD 988M 30M Dec/2024